Cambridge, MA, United States of America

Michael Shifrin

This inventor holds 1 USPTO granted patent. Top assignee: Momenta Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Shifrin. Retrieved from https://idiyas.com/inventor/michael-shifrin-wsn2i3o0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Shifrin: Innovator in Antibody Compositions

Introduction

Michael Shifrin is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody compositions. His work has led to advancements that could have a profound impact on therapeutic applications.

Latest Patents

Michael Shifrin holds a patent for "FCRN Antibody Compositions." This patent represents his innovative approach to enhancing the efficacy of antibody therapies. With 1 patent to his name, he is recognized for his contributions to the scientific community.

Career Highlights

Currently, Michael Shifrin is employed at Momenta Pharmaceuticals, Inc. His role at the company allows him to work on cutting-edge research and development projects. His expertise in antibody compositions is invaluable to the company's mission of advancing healthcare solutions.

Collaborations

Michael has collaborated with various professionals in his field, including his coworker Zhongli Zhang. Their combined efforts contribute to the innovative research being conducted at Momenta Pharmaceuticals.

Conclusion

Michael Shifrin is a dedicated inventor whose work in antibody compositions is paving the way for future advancements in biotechnology. His contributions are essential to the ongoing development of effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…